Stepwise androgen receptor dimerization

van Royen, Martin E., van Cappellen, Wiggert A., de Vos, Carola, Houtsmuller, Adriaan B., Trapman, Jan·2012·Journal of Cell Science
DOI 10.1242/jcs.096792

Cited by (144)

Items 101–144 of 144

  1. N/C Interactions Are Dispensable for Normal In Vivo Functioning of the Androgen Receptor in Male Mice
    Sarah El Kharraz, Vanessa Dubois, Kaisa‐Mari Launonen, Laura Helminen, Jorma J. Palvimo, Claude Libert, Elien Smeets, Lisa Moris, Roy Eerlings, Dirk Vanderschueren et al. · 2022 · Endocrinology
  2. A high-throughput platform for single-molecule tracking identifies drug interaction and cellular mechanisms
    David Trombley McSwiggen, Helen Liu, Ruensern Tan, Sebastia Agramunt Puig, Lakshmi B. Akella, Russell Berman, Mason Bretan, Hanzhe Chen, Xavier Darzacq, Kelsey Ford et al. · 2023 · eLife
  3. Microfluidics-Based Technologies for the Assessment of Castration-Resistant Prostate Cancer
    Amel Sassi, Lidan You · 2024 · Cells
  4. Discovery of JNJ-63576253, a Next-Generation Androgen Receptor Antagonist Active Against Wild-Type and Clinically Relevant Ligand Binding Domain Mutations in Metastatic Castration-Resistant Prostate Cancer
    Jonathan R. Branch, Tammy L. Bush, Vineet Pande, Peter J. Connolly, Zhuming Zhang, Ian Hickson, Janine Ondrus, Steffen Jaensch, James Robert Bischoff, Georges Habineza et al. · 2021 · Molecular Cancer Therapeutics
  5. The role of ubiquitination in spinal and bulbar muscular atrophy
    Medha Sengupta, Anna Pluciennik, Diane E. Merry · 2022 · Frontiers in Molecular Neuroscience
  6. The Transmembrane Protein TM4SF3 Interacts With AR and AR-V7 and is Recruited to AR Target Genes
    Prabesh Khatiwada, Ujjwal Rimal, Zhengyang Han, Mamata Malla, Jun Zhou, Lirim Shemshedini · 2023 · Endocrinology
  7. Genetic, Environmental, and Nuclear Factors Governing Genomic Rearrangements
    Susmita Gurjar Ramanand, Ram Shankar Mani · 2019 · Advances in experimental medicine and biology
  8. Phase Separation Mediated Sub-Nuclear Compartmentalization of Androgen Receptors
    Selçuk Yavuz, Tsion E. Abraham, Adriaan B. Houtsmuller, Martin E. van Royen · 2024 · Cells
  9. SWI/SNF chromatin remodelers in prostate cancer progression
    Sandra Carolina Ordonez‐Rubiano, Brayden P. Strohmier, Surbhi Sood, Emily C. Dykhuizen · 2024 · Frontiers in Epigenetics and Epigenomics
  10. A high-throughput platform for single-molecule tracking identifies drug interaction and cellular mechanisms
    David Trombley McSwiggen, Helen Liu, Ruensern Tan, Sebastia Agramunt Puig, Lakshmi B. Akella, Russell Berman, Mason Bretan, Hanzhe Chen, Xavier Darzacq, Kelsey Ford et al. · 2024 · eLife
  11. Structural perspectives on the androgen receptor, the elusive shape-shifter
    Madisyn J Johnson, Elizabeth V. Wasmuth · 2024 · Steroids
  12. Role of the Hsp90-Immunophilin Heterocomplex in Cancer Biology
    Sonia A. De Leo, Nadia R. Zgajnar, Gisela I. Mazaira, Alejandra G. Erlejman, Mario D. Galigniana · 2019 · Current Cancer Therapy Reviews
  13. The androgen receptor for the radiation oncologist
    L. Quéro, François Rozet, Philippe Beuzeboc, Christophe Hennequin · 2015 · Cancer/Radiothérapie
  14. A high-throughput platform for single-molecule tracking identifies drug interaction and cellular mechanisms
    David Trombley McSwiggen, Helen Liu, Ruensern Tan, Sebastia Agramunt Puig, Lakshmi B. Akella, Russell Berman, Mason Bretan, Hanzhe Chen, Xavier Darzacq, Kelsey Ford et al. · 2023 · eLife
  15. Dihydrotestosterone-androgen receptor signaling suppresses EBV-positive gastric cancer through DNA demethylation-mediated viral reactivation
    Miyeon Cho, Hyeji Byun, Sun Hee Lee, Sohyun Youn, Inuk Jung, Joohee Jung, Junho Lee, Hyosun Cho, Hyojeung Kang · 2025 · Gastric Cancer
  16. The evolution of eukaryotic linear motifs governing the function of androgen receptor from fish to Homo sapiens
    Antonella Falconieri, Giulia Boarolo, Chiara Boschelle, G. Spagnolli, Caterina Marchioretti, Emanuela Zuccaro, Isabella Palazzolo, L. Tosatto, A. K. Hegazy, J. Rosati et al. · 2025 · Nucleic Acids Research
  17. The transportosome system as a model for the retrotransport of soluble proteins
    Gisela I. Mazaira, Alejandra G. Erlejman, Nadia R. Zgajnar, Graciela Piwien‐Pilipuk, Mario D. Galigniana · 2023 · Molecular and Cellular Endocrinology
  18. Androgen receptor ubiquitination links KCTD13 to genitourinary tract defects
    Ahmed Chahdi, Carolina J. Jorgez, Jill Anne Rosenfeld, Neetu Neetu, Abhishek Seth · 2025 · The FASEB Journal
  19. Androgen Receptor in Health and Disease
    Marco Marcelli · 2017 · Springer eBooks
  20. Dichotomy in the Epigenetic Mark Lysine Acetylation is Critical for the Proliferation of Prostate Cancer Cells
    Ravi Ramesh Pathak, Marc Philizaire, Shiraz Mujtaba · 2015 · Cancers
  21. Androgen Receptor Signaling Interactions Control Epithelial–Mesenchymal Transition (EMT) in Prostate Cancer Progression
    Sarah K. Martin, Michael V. Fiandalo, Natasha Kyprianou · 2013 · Springer eBooks
  22. Deciphering the allosteric control of androgen receptor DNA binding by its disordered N-terminal domain
    Laurens W.H.J. Heling, Jolieke van der Veen, Adam P. Rofe, Eric West, Alba Jiménez-Panizo, Andrea Alegre‐Martí, Vahid Sheikhhassani, Julian Ng, Thomas Schmidt, Eva Estébanez‐Perpiñá et al. · 2025 · Molecular and Cellular Endocrinology
  23. Blocking the dimerization of polyglutamine-expanded androgen receptor protects cells from DHT-induced toxicity by increasing AR turnover
    A.E. Lisberg, Yuhong Liu, Diane E. Merry · 2024 · Journal of Biological Chemistry
  24. Mutant androgen receptor induces neurite loss and senescence independently of ARE binding in a neuronal model of SBMA
    Jordyn S Karliner, Yuhong Liu, Diane E. Merry · 2024 · Proceedings of the National Academy of Sciences
  25. Bedeutung der Androgenrezeptor-Spleißvariante AR-V7 für Prognose und Therapie des fortgeschrittenen Prostatakarzinoms
    Paul Thelen, Helge W. Taubert, Stefan M. Duensing, Glen Kristiansen, Axel S. Merseburger, Marcus Victor Cronauer · 2018 · Aktuelle Urologie
  26. NanoLuc Binary Technology as a methodological approach: an important new tool for studying the localization of androgen receptor and androgen receptor splice variant V7 homo and heterodimers
    Juan Carlos Guzmán, Katrin Weigelt, Angela Neumann, Philipp Tripal, Benjamin Schmid, Zoltán Winter, Ralf Palmisano, Zoran Čulig, Marcus Victor Cronauer, Paul Muschler et al. · 2024 · BMC Cancer
  27. Development of novel small molecule inhibitor of androgen receptor to treat castration-resistant prostate cancer
    Yu Chi Yang · 2016 · cIRcle (University of British Columbia)
  28. The Effects of Legacy and Emerging Persistent Organic Pollutants in Endocrine Signalling Pathways in Mammalian Cancer Cell Lines
    Lilian Wong · 2014 · Summit (Simon Fraser University)
  29. Inhibition of castration resistant prostate cancer by sintokamide A : an antagonist of the amino-terminus of the androgen receptor
    Iran Tavakoli · 2013 · cIRcle (University of British Columbia)
  30. Androgeenireseptorin tumatranslokaatio, FOXA1-vuorovaikutus ja liikkuvuus ihmisen soluissa
    Vesa Rahkama · 2012 · Jyväskylä University Digital Archive (University of Jyväskylä)
  31. Androgen Receptor Signaling in Castration Resistant Prostate Cancer
    Yu Zhao, Donald J. Tindall, Haojie Huang · 2016 · Springer eBooks
  32. Retroactivity effects dependency on the transcription factors binding mechanisms
    Libertad Pantoja-Hernández, Elena R Alvarez-Buylla, Carlos Fernando Aguilar-Ibañez, Adriana Garay‐Arroyo, A. Soria, Juan Carlos Martínez‐García · 2016 · Journal of Theoretical Biology
  33. Targeting epithelial to mesenchymal transition (EMT) to modulate prostate cancer cell chemoresistance
    Akanksha Upadhyaya · 2020 · Queensland University of Technology
  34. Development of novel androgen receptor inhibitors to overcome castrate-resistant prostate cancer
    Hilal Saraç, Artem R Cherkasov, Nathan A. Lack · 2021 · Elsevier eBooks
  35. Roles of sex phenotype and sex chromosome dosage in sex-biased DNA methylation
    Najla AlOgayil · 2021 · eScholarship@McGill (McGill)
  36. Androgen Receptors in the Pathology of Disease
    Jacky Kieran Leung, Amy H. Tien, Marianne D. Sadar · 2021 · Springer eBooks
  37. Faculty Opinions recommendation of ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer.
    Patricia V. Elizalde · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  38. Supplementary Data 3 from Discovery of JNJ-63576253, a Next-Generation Androgen Receptor Antagonist Active Against Wild-Type and Clinically Relevant Ligand Binding Domain Mutations in Metastatic Castration-Resistant Prostate Cancer
    Jonathan R. Branch, Tammy L. Bush, Vineet Pande, Peter J. Connolly, Zhuming Zhang, Ian Hickson, Janine Ondrus, Steffen Jaensch, James Robert Bischoff, Georges Habineza et al. · 2023
  39. Regulação do promotor SMyHC3 pelos receptores nucleares GR e COUP-TFII
    Izabella Tambones · 2020
  40. Drug Repurposing Patent Applications: April–June 2024
    Hermann AM Mucke · 2024 · Assay and Drug Development Technologies
  41. Androgenrezeptor in Gesundheit und Krankheit
    Alexandre Hohl, Marco Marcelli · 2024 · Springer eBooks
  42. Tracking Transcription Factors on the Genome by their DNase-seq Footprints
    Galip Gürkan Yardımcı · 2014 · DukeSpace (Duke University)
  43. Role of Underutilized Plant-Derived Metal Oxide-Based Nanoparticles Against Prostate Cancer
    Nidhi Bhardwaj, Indu Bhardwaj, Kanika Dulta, Eugenie Nepovimová, Kamil Kuča, Monika Choudhary, Parteek Mandyal, Ambika Choudhary, Lukas Peter · 2026 · Springer eBooks
  44. BindingDB Entry 50013848: Discovery of JNJ-63576253: A Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC).
    BindingDB · 2022 · UC San Diego